UNIFI INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that UNIFI INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $571.34M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $582.21M | Aug 26, 2025 |
| FY2025 | Jul 2, 2023 | $623.53M | Aug 26, 2025 |
| FY2024 | Jul 3, 2022 | $815.76M | Aug 23, 2024 |
| FY2023 | Jun 27, 2021 | $667.59M | Aug 25, 2023 |
| FY2022 | Jun 28, 2020 | $606.51M | Aug 31, 2022 |
| FY2021 | Jun 30, 2019 | $708.80M | Aug 25, 2021 |
| FY2018 | Jun 24, 2018 | $181.33M | Aug 22, 2018 |
| FY2018 | Mar 25, 2018 | $165.87M | Aug 22, 2018 |
| FY2018 | Dec 24, 2017 | $167.48M | Aug 22, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $138.54M | Aug 26, 2025 |
| FY2025 | Mar 30, 2025 | $146.56M | Aug 26, 2025 |
| FY2025 | Dec 29, 2024 | $138.88M | Aug 26, 2025 |
| FY2025 | Sep 29, 2024 | $147.37M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $157.45M | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | $149.00M | Aug 26, 2025 |
| FY2025 | Dec 31, 2023 | $136.92M | Aug 26, 2025 |
| FY2025 | Oct 1, 2023 | $138.84M | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | $151.06M | Aug 23, 2024 |
| FY2024 | Apr 2, 2023 | $156.74M | Aug 23, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 25, 2017 | $171.25M | Sep 1, 2017 |
| FY2017 | Mar 26, 2017 | $160.90M | Sep 1, 2017 |
| FY2017 | Dec 25, 2016 | $155.16M | Sep 1, 2017 |
| FY2017 | Sep 25, 2016 | $159.97M | Sep 1, 2017 |
| FY2017 | Jun 26, 2016 | $163.86M | Sep 1, 2017 |
| FY2017 | Mar 27, 2016 | $161.28M | Sep 1, 2017 |
| FY2017 | Dec 27, 2015 | $156.34M | Sep 1, 2017 |
| FY2017 | Sep 27, 2015 | $162.17M | Sep 1, 2017 |
| FY2016 | Jun 28, 2015 | $174.95M | Aug 26, 2016 |
| FY2016 | Mar 29, 2015 | $172.19M | Aug 26, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | ($1.13M) | Aug 26, 2025 |
| FY2025 | Mar 30, 2025 | ($445.0K) | Aug 26, 2025 |
| FY2025 | Dec 29, 2024 | $534.0K | Aug 26, 2025 |
| FY2025 | Sep 29, 2024 | $9.46M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $10.79M | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | $4.76M | Aug 26, 2025 |
| FY2025 | Dec 31, 2023 | $1.64M | Aug 26, 2025 |
| FY2025 | Oct 1, 2023 | ($575.0K) | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | $6.03M | Aug 23, 2024 |
| FY2024 | Apr 2, 2023 | $9.65M | Aug 23, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $15.47M | Aug 26, 2025 |
| FY2025 | Mar 30, 2025 | ($16.79M) | Aug 26, 2025 |
| FY2025 | Dec 29, 2024 | ($11.39M) | Aug 26, 2025 |
| FY2025 | Sep 29, 2024 | ($7.63M) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | ($3.98M) | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | ($10.30M) | Aug 26, 2025 |
| FY2025 | Dec 31, 2023 | ($19.85M) | Aug 26, 2025 |
| FY2025 | Oct 1, 2023 | ($13.27M) | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | ($15.29M) | Aug 23, 2024 |
| FY2024 | Apr 2, 2023 | ($5.18M) | Aug 23, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | ($9.52M) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | ($37.42M) | Aug 26, 2025 |
| FY2025 | Jul 2, 2023 | ($40.87M) | Aug 26, 2025 |
| FY2024 | Jul 3, 2022 | $28.60M | Aug 23, 2024 |
| FY2023 | Jun 27, 2021 | $38.61M | Aug 25, 2023 |
| FY2022 | Jun 28, 2020 | ($8.82M) | Aug 31, 2022 |
| FY2021 | Jun 30, 2019 | $10.96M | Aug 25, 2021 |
| FY2020 | Jun 24, 2018 | $28.80M | Aug 26, 2020 |
| FY2019 | Jun 25, 2017 | $43.77M | Aug 29, 2019 |
| FY2018 | Jun 26, 2016 | $42.20M | Aug 22, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $8.75M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $9.60M | Aug 26, 2025 |
| FY2025 | Jul 2, 2023 | $10.87M | Aug 26, 2025 |
| FY2024 | Jul 3, 2022 | $12.10M | Aug 23, 2024 |
| FY2023 | Jun 27, 2021 | $11.48M | Aug 25, 2023 |
| FY2022 | Jun 28, 2020 | $11.26M | Aug 31, 2022 |
| FY2021 | Jun 30, 2019 | $12.36M | Aug 25, 2021 |
| FY2020 | Jun 24, 2018 | $7.79M | Aug 26, 2020 |
| FY2019 | Jun 25, 2017 | $7.18M | Aug 29, 2019 |
| FY2018 | Jun 26, 2016 | $6.91M | Aug 22, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $49.01M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $46.63M | Aug 26, 2025 |
| FY2025 | Jul 2, 2023 | $47.35M | Aug 26, 2025 |
| FY2024 | Jul 3, 2022 | $52.49M | Aug 23, 2024 |
| FY2023 | Jun 27, 2021 | $51.33M | Aug 25, 2023 |
| FY2022 | Jun 28, 2020 | $43.81M | Aug 31, 2022 |
| FY2021 | Jun 30, 2019 | $52.69M | Aug 25, 2021 |
| FY2020 | Jun 24, 2018 | $56.08M | Aug 26, 2020 |
| FY2019 | Jun 25, 2017 | $50.83M | Aug 29, 2019 |
| FY2018 | Jun 26, 2016 | $47.50M | Aug 22, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | ($21.31M) | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $2.09M | Aug 26, 2025 |
| FY2025 | Jul 2, 2023 | $4.74M | Aug 26, 2025 |
| FY2024 | Jul 3, 2022 | $380.0K | Aug 23, 2024 |
| FY2023 | Jun 27, 2021 | $36.68M | Aug 25, 2023 |
| FY2022 | Jun 28, 2020 | $52.72M | Aug 31, 2022 |
| FY2021 | Jun 30, 2019 | $7.28M | Aug 25, 2021 |
| FY2020 | Jun 24, 2018 | $37.34M | Aug 26, 2020 |
| FY2019 | Jun 25, 2017 | $46.06M | Aug 29, 2019 |
| FY2018 | Jun 26, 2016 | $55.98M | Aug 22, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $10.49M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $11.19M | Aug 26, 2025 |
| FY2025 | Jul 2, 2023 | $36.43M | Aug 26, 2025 |
| FY2024 | Jul 3, 2022 | $39.63M | Aug 23, 2024 |
| FY2023 | Jun 27, 2021 | $21.18M | Aug 25, 2023 |
| FY2022 | Jun 28, 2020 | $18.51M | Aug 31, 2022 |
| FY2021 | Jun 30, 2019 | $24.87M | Aug 25, 2021 |
| FY2020 | Jun 24, 2018 | $25.03M | Aug 26, 2020 |
| FY2019 | Jun 25, 2017 | $33.19M | Aug 29, 2019 |
| FY2018 | Jun 26, 2016 | $52.34M | Aug 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $426.87M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $469.24M | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | $538.82M | Aug 23, 2024 |
| FY2023 | Jul 3, 2022 | $588.72M | Aug 25, 2023 |
| FY2022 | Jun 27, 2021 | $555.37M | Aug 31, 2022 |
| FY2021 | Jun 28, 2020 | $474.16M | Aug 25, 2021 |
| FY2021 | Jun 30, 2019 | $592.15M | Aug 25, 2021 |
| FY2020 | Jun 24, 2018 | $601.81M | Aug 26, 2020 |
| FY2019 | Jun 25, 2017 | $571.50M | Aug 29, 2019 |
| FY2018 | Jun 26, 2016 | $525.44M | Aug 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $177.40M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $205.86M | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | $215.21M | Aug 23, 2024 |
| FY2023 | Jul 3, 2022 | $227.27M | Aug 25, 2023 |
| FY2022 | Jun 27, 2021 | $196.95M | Aug 31, 2022 |
| FY2021 | Jun 28, 2020 | $158.01M | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $199.31M | Aug 26, 2020 |
| FY2019 | Jun 24, 2018 | $212.03M | Aug 29, 2019 |
| FY2018 | Jun 25, 2017 | $210.70M | Aug 22, 2018 |
| FY2017 | Jun 26, 2016 | $198.50M | Sep 1, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 30, 2019 | $392.85M | Aug 29, 2019 |
| FY2019 | Jun 24, 2018 | $389.78M | Aug 29, 2019 |
| FY2018 | Jun 25, 2017 | $360.81M | Aug 22, 2018 |
| FY2017 | Jun 26, 2016 | $325.03M | Sep 1, 2017 |
| FY2016 | Jun 28, 2015 | $297.49M | Aug 26, 2016 |
| FY2015 | Jun 29, 2014 | $285.02M | Sep 3, 2015 |
| FY2014 | Jun 30, 2013 | $284.91M | Sep 10, 2014 |
| FY2013 | Jun 24, 2012 | $289.52M | Sep 10, 2013 |
| FY2012 | Jun 26, 2011 | $299.66M | Aug 30, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $239.05M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $259.40M | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | $306.79M | Aug 23, 2024 |
| FY2023 | Jul 3, 2022 | $353.14M | Aug 25, 2023 |
| FY2022 | Jun 27, 2021 | $344.80M | Aug 31, 2022 |
| FY2021 | Jun 28, 2020 | $315.72M | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $374.67M | Aug 26, 2020 |
| FY2019 | Jun 24, 2018 | $371.75M | Aug 29, 2019 |
| FY2018 | Jun 25, 2017 | $339.94M | Aug 22, 2018 |
| FY2017 | Jun 26, 2016 | $307.07M | Sep 1, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | $22.66M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | $26.81M | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | $46.96M | Aug 23, 2024 |
| FY2023 | Jul 3, 2022 | $53.29M | Aug 25, 2023 |
| FY2022 | Jun 27, 2021 | $78.25M | Aug 31, 2022 |
| FY2021 | Jun 28, 2020 | $75.27M | Aug 25, 2021 |
| FY2021 | Jun 30, 2019 | $22.23M | Aug 25, 2021 |
| FY2021 | Jun 24, 2018 | $44.89M | Aug 25, 2021 |
| FY2020 | Jun 25, 2017 | $35.43M | Aug 26, 2020 |
| FY2019 | Jun 26, 2016 | $16.65M | Aug 29, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $0 | Aug 23, 2024 |
| FY2024 | Jul 2, 2023 | $1.63M | Aug 23, 2024 |
| FY2023 | Jul 3, 2022 | $729.0K | Aug 25, 2023 |
| FY2022 | Jun 27, 2021 | $882.0K | Aug 31, 2022 |
| FY2012 | Jun 24, 2012 | $121.55M | Aug 30, 2012 |
| FY2012 | Jun 26, 2011 | $168.66M | Aug 30, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | 0 | Aug 26, 2025 |
| FY2025 | Mar 30, 2025 | 0 | Aug 26, 2025 |
| FY2025 | Dec 29, 2024 | 0 | Aug 26, 2025 |
| FY2025 | Sep 29, 2024 | 0 | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Aug 26, 2025 |
| FY2025 | Dec 31, 2023 | (1) | Aug 26, 2025 |
| FY2025 | Oct 1, 2023 | 0 | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | 0 | Aug 23, 2024 |
| FY2024 | Apr 2, 2023 | 0 | Aug 23, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | 0 | Aug 26, 2025 |
| FY2025 | Mar 30, 2025 | 0 | Aug 26, 2025 |
| FY2025 | Dec 29, 2024 | 0 | Aug 26, 2025 |
| FY2025 | Sep 29, 2024 | 0 | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Aug 26, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Aug 26, 2025 |
| FY2025 | Dec 31, 2023 | (1) | Aug 26, 2025 |
| FY2025 | Oct 1, 2023 | 0 | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | 0 | Aug 23, 2024 |
| FY2024 | Apr 2, 2023 | 0 | Aug 23, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 29, 2025 | 18.36M | Aug 26, 2025 |
| FY2025 | Jun 30, 2024 | 18.25M | Aug 26, 2025 |
| FY2024 | Jul 2, 2023 | 18.08M | Aug 23, 2024 |
| FY2023 | Jul 3, 2022 | 17.98M | Aug 25, 2023 |
| FY2022 | Jun 27, 2021 | 18.49M | Aug 31, 2022 |
| FY2021 | Jun 28, 2020 | 18.45M | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | 18.46M | Aug 26, 2020 |
| FY2019 | Jun 24, 2018 | 18.35M | Aug 29, 2019 |
| FY2018 | Jun 25, 2017 | 18.23M | Aug 22, 2018 |
| FY2017 | Jun 26, 2016 | 17.85M | Sep 1, 2017 |